Search
  • Investor Portal
  • Contact
Amadeus Capital
  • Home
  • Who we are
    • The Team
  • How we invest
    • Submit a proposal
  • Companies
    • AI and Machine Learning
    • Consumer Services
    • Cyber Security
    • Digital Health and Medical Technology
    • Digital Media
    • Enterprise Software
    • FinTech, InsurTech and RegTech
    • Semiconductors and Displays
    • Telecoms Infrastructure
  • Careers
    • Portfolio Companies
    • Amadeus
  • News
    • Press Releases
    • Blogs
    • Podcasts
    • Video Library
    • Downloads
  • Investor relations
    • Amadeus Investor Portal
    • Amadeus Early Stage EIS Fund and Portal
  • Investor Portal
  • Contact

Home > News > Press Releases > Healx

Press Release

Latest Press Release: 26th July 2018

Healx raises $10m as investors back AI to find rare disease treatments faster

Cambridge, UK – 26th July, 2018 – Healx (https://healx.io), the Cambridge (UK) technology company developing breakthrough treatments for rare diseases, today announced a $10 million Series A funding round, led by Balderton Capital, Europe's leading early-stage venture investor. Existing investors, Jonathan Milner and Amadeus Capital Partners also participated in the round.

Read in full

  • Press Release: 4th October 2016

    Healx secures £1.5m from Amadeus Capital and investors to combat rare diseases

    Machine learning and advanced analytics help Healx identify new uses for existing drugs London, UK – 4 Oct 2016 – Amadeus Capital Partners, the global technology investor, has made an early-stage investment in Healx , an innovative British healthcare company that seeks new uses for existing drugs in the fight against rare diseases. Amadeus [...]

    • How we invest

    • Have you seen...

      Meet the team

    • Resources

    • Terms & Conditions
    • Privacy Policy
    • Cookie Policy
    • Site Credits

    © Copyright 2023 Amadeus Capital Partners Ltd

    Authorised and regulated by the Financial Conduct Authority

    This website uses cookies to improve your experience. If you continue to use our website then you agree to this.More info OK

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
    Non-necessary
    Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
    SAVE & ACCEPT